EcoDrugPlus

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSVPAG00000010244
Gene Symbol: HSD11B1
1 Cross references
248 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSVPAG00000004228
Gene Symbol: HCRTR2
3 Cross references
201 Possible Orthologues:

Indoleamine 2,3-Dioxygenase 1

Ensembl ID : ENSVPAG00000009779
Gene Symbol: IDO1
1 Cross references
98 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSVPAG00000006405
Gene Symbol: IGF1R
1 Cross references
274 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSVPAG00000003961
Gene Symbol: ITGA4
1 Cross references
236 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSVPAG00000005610
Gene Symbol: ITGAV
1 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSVPAG00000007825
Gene Symbol: ITGB1
1 Cross references
299 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSVPAG00000002715
Gene Symbol: ITGB6
1 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSVPAG00000002085
Gene Symbol: ITGB8
1 Cross references
202 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSVPAG00000001349
Gene Symbol: IRAK4
1 Cross references
202 Possible Orthologues:

Interleukin 5

Ensembl ID : ENSVPAG00000003840
Gene Symbol: IL5
3 Cross references
91 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSVPAG00000009700
Gene Symbol: IDH1
1 Cross references
234 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).